OVERVIEW

Vision: Patient-Centered Global Biopharmaceutical Company

Our Mission is: To develop innovative new therapeutics in tumor,
And to provide precision oncology platform technology.

AVATA PANCANCER 60 TEST

We know that every patient’s cancer and tumour is different. What works for a patient might not work for another. This is why we are focused on developing and offering precision
cancer tests and treatments, just so that every patient has a chance to receive the most optimal cancer treatment.
The AVATA PanCancer 60 test is a comprehensive precision cancer test. The test screens your tumour for drug sensitivities with AVATASCAN®, combined with next-generation sequencing
(NGS) genetic analysis and immune profiling of your tumour, and provides you and your oncologist with a personalised actionable report to recommend the best treatment for you.

WE KNOW THAT EVERY PATIENT’S CANCER AND TUMOUR IS DIFFERENT. WHAT WORKS FOR A PATIENT MIGHT NOT WORK FOR ANOTHER. THIS IS WHY WE ARE FOCUSED ON DEVELOPING AND OFFERING PRECISION
CANCER TESTS AND TREATMENTS, JUST SO THAT EVERY PATIENT HAS A CHANCE TO RECEIVE THE MOST OPTIMAL CANCER TREATMENT.
THE AVATA PANCANCER 60 TEST IS A COMPREHENSIVE PRECISION CANCER TEST. THE TEST SCREENS YOUR TUMOUR FOR DRUG SENSITIVITIES WITH AVATASCAN®, COMBINED WITH NEXT-GENERATION SEQUENCING
(NGS) GENETIC ANALYSIS AND IMMUNE PROFILING OF YOUR TUMOUR, AND PROVIDES YOU AND YOUR ONCOLOGIST WITH A PERSONALISED ACTIONABLE REPORT TO RECOMMEND THE BEST TREATMENT FOR YOU.